Evidence map›Paper›PMID 37258171›Full record

ArticleInternal medicine (Tokyo, Japan)2024

Left Main Bronchus Obstruction in a Patient with Small-cell Lung Cancer Successfully Treated with Venovenous Extracorporeal Membrane Oxygenation.

Tatsuya Nagai, Kyoko Yoshida, Ayumu Otsuki, Yuko So, Toshiyuki Karumai, Hiroshi Sugimura, Yuri Tachibana, Junya Fukuoka, Hiroyuki Ito, Kei Nakashima

Open access · diamondAbstract readCase Reports
In one paragraph

Article in Internal medicine (Tokyo, Japan), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.3field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Tatsuya NagaiDepartment of Pulmonology, Kameda Medical Center, Japan.
Kyoko YoshidaDepartment of Pulmonology, Kameda Medical Center, Japan.
Ayumu OtsukiDepartment of Pulmonology, Kameda Medical Center, Japan.
Yuko SoDepartment of Intensive Care Medicine, Kameda Medical Center, Japan.
Toshiyuki KarumaiDepartment of Intensive Care Medicine, Kameda Medical Center, Japan.
Hiroshi SugimuraDepartment of Thoracic Surgery, Kameda Medical Center, Japan.
Yuri TachibanaDepartment of Clinical Pathology, Kameda Medical Center, Japan.
Junya FukuokaDepartment of Clinical Pathology, Kameda Medical Center, Japan.
Hiroyuki ItoDepartment of Pulmonology, Kameda Medical Center, Japan.
Kei NakashimaDepartment of Pulmonology, Kameda Medical Center, Japan.
Kameda Medical Center · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Lung cancer can cause fatal central airway obstruction. Rapid airway clearance is necessary in some cases, but ventilator management may be insufficient to maintain oxygenation levels. Venovenous extracorporeal membrane oxygenation (VV-ECMO) may be an effective rescue therapy for respiratory failure, but its efficacy in treating tumor-related airway obstruction is unknown. We herein report a case of central airway obstruction and severe acute respiratory failure due to small-cell lung cancer successfully treated with VV-ECMO, bronchoscopic airway intervention, and chemotherapy. VV-ECMO can be an effective option for the treatment of central airway obstruction with acute respiratory failure due to lung cancer.

Indexed as

Airway ObstructionExtracorporeal Membrane OxygenationLung NeoplasmsRespiratory Distress SyndromeRespiratory InsufficiencySmall Cell Lung CarcinomaBronchiHumansairway obstructionbronchoscopic surgeryextracorporeal membrane oxygenationlung cancerrespiratory failure

Identifiers

PMID37258171
PMCPMC10864078
OpenAlexW4378952319

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.